Pfizer: A Phase 2, Multi-Cohort Study to Evaluate the Impact of Prophylactic Intervention on Dermatologic and Gastrointestinal Adverse Events and Patient Reported Outcomes in Patients Treated with Dacomitinib (PF-00299804)

Project: Research

Status	Finished
Effective start/end date	02/28/13 → 11/18/16

Project Details